Breadcrumb

IDIGH  |  Infectious Diseases and Immunity in Global Health Program

News

Two studies confirm efficiency of saliva tests for COVID-19

Testing is the cornerstone of the fight against COVID-19, and a test that can be self-administered would greatly increase the options for case...

Could an antidepressant slow COVID-19 progression?

RI-MUHC researchers launch a clinical trial of fluvoxamine, a drug that has already proven efficient in reducing lung injury in animal studies and...

RI-MUHC researcher Nitika Pant Pai advocates improved access to HIV self-testing for Canadians

Canada approves HIV self-testing kit ahead of World AIDS Day 2020

Paving the way for COVID-19 research

RI-MUHC and McGill Containment level 3 Labs receive $1M in funding to accelerate research with live SARS Cov-2

Spike in peanut and nut anaphylaxis in children at Halloween and Easter

New study suggests education and awareness are needed to help reduce risk of anaphylaxis at specific times of the year

$2M funding to mitigate COVID-19 impact on tuberculosis services

Dr. Madhukar Pai launches studies in India, Indonesia, Nigeria and Peru

Containment Level 3 facilities advance COVID-19 research at the RI-MUHC and McGill

Infrastructure to study COVID-19 in a secure environment is creating new possibilities for collaboration and discovery

From silent infection to rapid death: Why are some people more vulnerable to COVID-19?

Scientists discover genetic and immunological causes of 15 percent of life-threatening COVID-19 cases

New study of therapy options in metastatic melanoma

RI-MUHC researchers lead “real-world” analysis of treatment patterns with checkpoint inhibitors

Lashanda Skerritt awarded Vanier Canada Graduate Scholarship

“I am constantly reminded that community involvement and advocacy are important drivers of scientific and medical knowledge,” says the RI-MUHC...

Inappropriate prescriptions sending hospitalized seniors back to the ER

Improving hospital prescribing practices may reduce risk of rehospitalization and death

Early treatment trial of hydroxychloroquine shows no symptomatic benefit for COVID-19 patients

Adult outpatients with mild symptoms of COVID-19 don’t benefit from taking hydroxychloroquine

A good showing for the IDIGH Program in 2020-2021 FRQS awards

Congratulations to researchers and trainees!

Recipient of the 2020-2021 Dr. Margaret Becklake Fellowship: Mikashmi Kohli

A postdoctoral fellow from the RI-MUHC is recognized for international work on TB diagnostics

Three COVID-19 projects at the RI-MUHC to receive CIHR funding

A $109M fund aims to mitigate impact of the pandemic on care delivery in Canada and beyond, as well as contribute to better understanding of the disease

COVID-19 pandemic: Looking back to better tackle future challenges

In two recent studies, RI-MUHC researchers provide useful information for evaluating public health strategies

Innovation Moves Online for the 2020 McGill Clinical Innovation Competition

RI-MUHC research team, Emily McDonald and Todd C. Lee, ties for Marika Zelenka Roy Innovation Prize

COVID-19 impact on cancer patients: MUHC researchers take part in a multinational study

Published in The Lancet, the study reveals cancer-specific factors associated with increased mortality